REACH PC Trial: Early Palliative Care Via Telehealth Has Equivalent Efficacy to On-Site Visits for Patients With Advanced NSCLC pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.
Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual Meeting itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
Median overall survival of 20.6 months was observed following two administrations of CAN-2409 + valacyclovir in NSCLC patients with progressive disease despite immune checkpoint inhibitor therapy.
Penn Medicine at the 2024 ASCO Annual Meeting newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.
While there are considerable barriers to incorporating comprehensive genotyping, the use of circulating tumor DNA offers an improvement in molecular testing and doing so earlier can accelerate the time to treatment and improve survival for patients with lung cancer.